Jane Street’s RAPT Therapeutics RAPT Stock Holding History

Jane Street’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-69,000	Closed	-$2.34M	–	12736
2025 Q4	$2.34M	Buy	+69,000	New	+$2.14M	﹤0.01%	4503
2022 Q4	–	Sell	-8,000	Closed	-$1.54M	–	9953
2022 Q3	$1.54M	Buy	+8,000	New	+$1.51M	﹤0.01%	4635
2022 Q1	–	Sell	-3,075	Closed	-$904K	–	10902
2021 Q4	$904K	Buy	3,075 +1,200	+64%	+$321K	﹤0.01%	6113
2021 Q3	$466K	Sell	1,875 -5,725	-75%	-$1.51M	﹤0.01%	7412
2021 Q2	$1.93M	Buy	7,600 +3,737	+97%	+$698K	﹤0.01%	4400
2021 Q1	$686K	Buy	+3,863	New	+$637K	﹤0.01%	6207

Jane Street's RAPT Position: Q1 2026 in Review

Jane Street sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 84,778 shares — an estimated $2.87M sold.

Jane Street first reported a position in RAPT in Q2 2020 and held it in 10 quarters. The position peaked at $2.87M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Jane Street reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 84,778 RAPT Therapeutics shares in Q1 2026, an estimated $2.87M.
Jane Street first reported a position in RAPT Therapeutics in Q2 2020 and held it in 10 quarters.
Jane Street's RAPT Therapeutics position peaked at $2.87M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.